all report title image

HEREDITARY ANGIOEDEMA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Hereditary Angioedema Market is segmented By Type (Hereditary Angioedema Type I and Hereditary Angioedema Type II), By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI1292
  • Page number: 152
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Hereditary Angioedema Market, By Type
      • Hereditary Angioedema Market, By Drug Class
      • Hereditary Angioedema Market, By Route of Administration
      • Hereditary Angioedema Market, By Distribution Channel
      • Hereditary Angioedema Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Epidemiology
    • Pipeline Analysis
  4. Hereditary Angioedema Market, By Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hereditary Angioedema Type I
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Hereditary Angioedema Type II
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Hereditary Angioedema Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • C1 Esterase Inhibitor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Kallikrein Inhibitor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Bradykinin Receptor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Attenuated Androgens
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Hereditary Angioedema Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Intravenous
    • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Hereditary Angioedema Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Hereditary Angioedema Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • CSL Behring
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Orchard Therapeutics plc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pharming Group N.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BioCryst Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ionis Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Attune Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Arrowhead Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Adverum Biotechnologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • KalVista Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CENTOGENE N.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Hereditary Angioedema Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.